echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Study of Nervous System > JAMA: Effect of in-vascular therapy on the 90-day functional prognosis of pre-circulating large vascular thrombosis stroke patients after in vitro therapy vs thrombosis

    JAMA: Effect of in-vascular therapy on the 90-day functional prognosis of pre-circulating large vascular thrombosis stroke patients after in vitro therapy vs thrombosis

    • Last Update: 2021-01-22
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    Several studies have confirmed that intravascular treatment after venous thrombosis (IVT) in stroke patients with pre-circulating large vascular thrombosis can maximize the benefits to patients.
    IVT has advantages over intracvascular treatment, but there are also certain risks: some patients receive IVT can be exempted from intracvascular treatment, and IVT can promote intracvascular refill, promote the dissolution of downstream micro-embolism, improve the far-end microcirculation;
    recently, researchers examined patients with travascular reforestation stroke, compared with intravenous thrombosis combined with intravascular therapy, the effect of intravascular treatment on the prognosis of patients.
    the study was conducted in 33 stroke centers in China and was a multi-center, randomized, non-inefficient trial.
    234 adult patients participated, patients for near-end front circulatory intracranial thrombosis stroke, symptoms appeared within 4.5 hours of treatment, and follow-up 90 days, of which 116 people received simple intravascular thrombosis treatment, 118 people received atipase venous thrombosis after vascular thrombosis.
    of the study was the proportion of patients with 90-day prognostic independence, defined as RanKin score 0-2, and non-poor performance boundary of -10%.
    the trial was terminated early due to efficacy factors.
    all 234 patients (with an average age of 68 years; 102 women (43.6 per cent)) completed the trial.
    In the 90-day follow-up, 63 patients (54.3%) in the vascular thrombosis group were assessed to have functional prognosis independence, while 55 patients (46.6%) in the combined treatment group achieved functional independence (difference: 7.7%) in the 90-day follow-up, reaching the non-inferior endpoint. there was no significant difference between
    groups in symptomatic cerebral hemorrhage (6.1% vs 6.8%; difference: -0.8%) and 90-day mortality (17.2% vs17.8%; difference: -0.5%).
    the study concluded that for patients with ischemic stroke caused by near-end pre-circulatory cysts within 4.5 hours of onset, the 90-day functional prognosis independent rate achieved by intravascular therapy alone was comparable to that of combined therapy.
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.
    Related Articles

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent Echemi's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.